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When the  phenomenon of acquired immunological tolerance was first de- 
scribed it was believed that all cells possess the same array of transplantation 
antigens (1). Indeed, even after the demonstration that some fetal or neonatal 
animals injected with allogeneic lymphoid cells permanently accept these cells 
but do not permanently accept skin allografts of the same genetic origin, it was 
presumed that rejection results from the greater susceptibility of skin to trans- 
plantation immunity (2). We now know that the ability of permanent hemo- 
poietic chimeras to reject skin grafts from the hemopoietic cell donor is due to 
skin-specific (Sk)  1 antigens. Thus, Boyse and his associates (3) observed that 
adult C57BL/6 (hereafter B6) mice lethally irradiated and restored with (B6  x 
A)  hemopoietic cells  subsequently reject  (B6  x  A)  or  A-strain skin  grains, 
although cytotoxicity and hemagglutination tests fail to distinguish between 
these chimeric recipients and normal (B6 x A) controls. It seems, therefore, that 
the A-strain skin grafts are rejected by (B6 x A) lymphoid cells which have lost 
tolerance of A-strain Sk antigens after being transferred to recipients which do 
not express these antigens. (The possibility remains that rejection in this system 
is mediated by a residuum of radiation-resistant host cells.) Further support for 
this contention is provided by the finding that tolerance of putative Sk antigens 
is maintained when A-strain epidermal cells are administered intravenously 
and intraperitoneally at the time of irradiation and restoration (4). 
Whereas these results are in accord with the concept of Sk antigen they do not 
agree with previous studies concerned  with tolerance induction in neonatal mice 
(2). These early studies indicate that the resistance of neonatal B6 mice to the 
induction of tolerance of A-strain skin allografts can be overcome if they are 
exposed to a sublethal dose of X irradiation before they are inoculated with a 
suspension of (A × B6) lymphoid cells. Thus, 12 of 24 B6 mice exposed to 460 R 
and 20 million (A  x  B6) spleen cells at birth, were subsequently found to be 
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highly tolerant of  A-strain skin grafts; i.e., such grat~cs survived for more than 50 
days. However, since four of these animals rejected their grat~s by the 56th day 
after transplantation and since no grafts were followed for more than 60 days, it 
is conceivable  that all  grafts might  have  been destroyed eventually  had the 
observation period been extended. In this case rejection would be consistent with 
the notion of Sk antigen. 
In the experiments described below the observation period was extended to 
determine whether neonatally X irradiated B6 animals,  inoculated with (A  x 
B6) lymphoid cells and subsequently challenged with A skin graf~s, ultimately 
reject these grafts while maintaining their chimeric state.  Moreover,  the re- 
sponse of these mice to adult skin grafts was compared with their response to 
skin gra~s from neonatal donors. 
Materials and Methods 
Mice.  Male and female mice of the isogenic B6/Ss (H-2  b) and A/Ss (H-2  ~) strains as well as (A 
x  B6)F1 hybrids of these two strains were used. 
Tolerance Induction.  When less than 18-h old, B6 and A mice were inoculated intravenously, 
via the orbital branch of the anterior facial vein, with 20 million spleen and lymph node cells from 
(A x  B6) donors (5). 
Cell Suspensions.  All cell suspensions were prepared in Hanks' balanced salt solution accord- 
ing to procedures described elsewhere (5).  Cells were administered in a  standard vol of 0.1 ml of 
medium. 
Irradiation.  Mice which were  irradiated before receiving the tolerance-inducing inoculum, 
were exposed to 400 or 500 R from a  laTCs source. 
Skin Grafting.  All  neonatally inoculated  B6 animals were  challenged with strain A  skin 
grafts and all treated A  mice received B6 skin grafts after 12-14 wk  (6).  The skin grafts were 
prepared from the ventrum of adult female donors or from females less than 24 h of age. All grafts 
were full thickness disks of skin measuring 1.2-1.5 cm in diameter. Graft beds were prepared in 
the lateral thoracic wall of the hosts. First and third grafts were always transplanted on the right 
side of the body and second grafts on the left side. Primary inspections were carried out at 8 or 9 
days after transplantation and grafts were evaluated daily for 30 days and twice weekly thereaf- 
ter.  Surviving neonatal skin grafts were observed for at least 200 days and adult grafts were 
observed for at least 100 days. Animals were tested for cellular chimerism after they had rejected 
their test grafts by hemagglutination and cytotoxicity tests. 
Hemagglutination Test.  Hemagglutination was accomplished according to the procedure of 
Gorer and Mikulska  (7) with the following modifications: 0.3 ml whole blood (drawn from the 
retroorbital sinus) was added to 2.0 ml sodium citrate solution (3.8 g sodium citrate-100 ml of 0.85% 
saline/100 ml distilled water). Erythrocytes (RBC) were centrifuged at 150g for 10 min and washed 
twice in 2-5 ml saline.  0.01  ml packed  RBC  was then suspended in 0.15  ml heat-inactivated, 
gamma globulin-free fetal bovine serum and one drop of this suspension was reacted in plastic 
hemagglutination trays with one drop of typing sera (B6 anti-ASL1, a  strain A  leukemia; or A 
anti-ERLD,  a  strain B6  leukemia)  diluted  1/32 and  1/128 with dextran-dextrose  saline  (1.8% 
dextran, average tool wt 115,000-1.08% dextrose). Controls included the dextran-dextrose saline 
but omitted the antiserum.  Hemagglutination trays were covered to prevent evaporation,  and 
incubated at 37°C for 90 min. Tests were read on glass slides by tilting the mixture and comparing 
controls with the two serum dilutions. 
Cytotoxicity  Test.  The cytotoxicity test was performed essentially according to  the method 
described by Boyse et al.  (8),  using lymphocytes obtained from biopsied axillary and brachial 
lymph nodes. Briefly, equal volumes (0.05 ml) of H-2 antiserum (serially diluted, e.g.,  1/40 to 1/ 
320),  lymphocyte  suspensions  (5  ×  10  e  cells/ml),  and  absorbed  guinea  pig  serum  diluted  1/4 
(complement source), were incubated at 37°C for 45 min in a rocking water bath. After incubation 
the tests were placed on ice. A freshly prepared solution of trypan blue dye was added to each tube, 
and the cells were counted in a  hemacytometer. Dead cells stained with the dye. 
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TABLE  I 
Survival of  Adult Strain A Skin Grafts on B6 Mice Inoculated at Birth with 20 Million 
(A  x B6)F1 Lymphoid Cells 
No. of  ani- 
Sex  of  recipients  mals  Graft  survival  times  MST  SD 
ff  15 
mm  11 
ff and mm  26 
days 
2 x 9, 10, 3 x 12, 7 × 13, 15, 16  12.2  1.21 
9, 2 x 10, 2 x 12, 6 x 13  12.0  1.25 
3 x 9, 3 x 10, 5 × 12, 13 x 13, 15, 16  12.1  1.18 
Results 
Survival of Adult Strain A  Skin Grafts on B6 Mice Inoculated at Birth with 
(A  x  B6) Cells.  The first experiment was performed to confirm the report (2) 
that it is not possible to render B6  mice more than slightly unresponsive of 
strain A skin grafts by exposing them at birth to (A  x  B6) spleen and lymph 
node cells. Accordingly, 26 neonatal B6 mice,  15 females and 11  males, were 
inoculated with 20  x  106 of these cells and were subsequently challenged with 
strain A skin grafts. As noted in Table I none of these grafts survived for more 
than 16 days (MST,  12.1 days). The MST of strain A skin on 22 untreated B6 
mice was about 8 days with none of the grafts surviving more than 9 days. 
Survival of  Adult A  Skin Grafts on X-Irradiated B6 Mice Inoculated at Birth 
with (A  x  B6) Cells.  To determine whether neonatal B6 mice could be made 
tolerant of A skin grafts if the recipients were exposed to X irradiation before 
receiving  (A  x  B6)  lymphoid cells,  as  previously reported  (2), B6  newborns 
received either 400 or 500 R before they were inoculated with (A x  B6) lymphoid 
cells. Although the mortality after this treatment was not recorded, we estimate 
that at least 50% of the subjects died before they could be challenged with skin 
grafts. Nevertheless, 13 recipients (6 females and 7 males) of 400 R and 29  (13 
females and  16  males) which received 500  R  survived in apparently healthy 
condition. The response of these animals to strain A skin grafts is summarized 
in Table II. Although these grafts survived for significiantly  longer periods than 
similar  grafts  on  unirradiated  animals,  and  although they appear  to  have 
survived better on males than on females, no graft survived for more than 69 
days. These rejections were not accompanied by a  loss of cellular chimerism. 
Thus,  when 21  animals in this experiment were tested serologically for the 
persistence of (A x  B6) cells all proved to be highly chimeric, even though 10 of 
these animals had rejected their A-strain skin graft.s within 14 days (see Table 
II). 
Survival of Neonatal Strain A  Skin Grafts on B6 Mice Inoculated at Birth 
with (A  x B6) Cells.  When only weak histoincompatibilities prevail, neonatal 
skin  grafts often survive in  situations where  adult skin grafts of the  same 
genotype are rejected (10-12). Therefore, we wished to determine how irradiated 
B6 mice inoculated at birth with (A x  B6) cells would behave towards neonatal 
A-strain grafts. Accordingly 35 such mice (13 females and 22 males which had 
received 500 R) were challenged with neonatal A-strain skin grafts: In contrast 
to  the  eventual  destruction of all  adult  A-strain  skin  grafts  on  identically 
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TABLE  II 
Survival of Adult Strain A Skin Grafts on B6 Mice Inoculated at Birth with 20 Million 
(A  × B6)F1 Lymphoid Cells after Receiving X Irradiation 
X-ray  No. of  Sex  Graft survival times  MST  SD  dose  animals 
400R  6  ff  2 x 12, 13, 15, 18, 20  13.5  1.33 
7  mm  14, 2 x 15, 19, 22, 23, 51  19.0  1.22 
13"  mmandff  2 x  12, 13, 14, 3 × 15, 18, 19, 20,  18.3  1.34 
22, 23, 51 
500R  13  ff 
16  mm 
29*  mm and ff 
5 × 13, 3 × 14, 15, 16, 17, 23, 45  13.2  1.20 
4 × 13, 18, 20, 22, 24, 25, 27, 30, 36,  24.0  1.88 
41, 44, 65, 69 
9 x  13, 3 x  14, 15, 16, 18, 20, 22,  17.2  1.98 
23, 24, 25, 2 × 27, 30, 36, 41, 44, 
45, 65, 69 
* Two females with grafts surviving 12 and 13 days and six males with grafts surviving 14, 2 x 15, 
22, 23, and 51 days tested for chimerism. 
* Eight females with graits surviving 3 × 13, 3 x 14, 15, and 27 days and five males with grafts 
surviving  13, 18, 36, 44, and 65 days tested for chimerism. 
throughout the observation period of 200 days (Table III). Indeed, 26 of the 35 
grafts survived longer than the longest surviving adult skin grafts.  Moreover, 
whereas 9/13 (69%) females rejected such grafts, only 6/20 (30%) males did so. 
Because of the prolonged and in most instances  indefinite survival of these 
neonatal grafts on irradiated recipients, we wished to learn whether such grafts 
would  survive  as  well  on  similarly  inoculated  but  unirradiated  hosts.  The 
persistence of neonatal A  skin grafts on inoculated but unirradiated B6 hosts 
would indicate that failure of adult A skin grafts to survive on similarly treated 
hosts is due not to H-2 antigens but to weaker (putative Sk) antigens.  In this 
event, the resistance of unirradiated neonatal B6 mice to tolerance induction 
(with respect to adult A  skin) could be attributed to their ability to respond to 
weak (Sk) but not strong  (H-2) antigens  (13). We found that although unirra- 
diated B6 animals which had received (A ×  B6) lymphoid cells at birth occasion- 
ally accepted neonatal A  strain grafts slightly longer than adult A  grafts, the 
MST's  of both adult  and  neonatal  grafts were similar  (Table IV).  Moreover, 
when 17 inoculated but unirradiated B6 animals were assayed for H-2  a antigens 
after they had rejected their test grafts, none proved to be chimeric. 
Capacity of Neonatal Skin Grafts to Induce Unresponsiveness of Adult Skin 
Grafts.  With respect to weak antigenic differences, neonatal skin grafts not 
only survive longer than adult grafts, but they also may induce unresponsive- 
ness of the latter  (10-12). This phenomenon is most frequently observed when 
the  neonatal  graft  has  been  in  residence  for  some  time  before  the  host  is 
challenged with the adult graft. Therefore, we wished to determine the fate of 
adult  A-strain  grafts  on  B6  hosts  which  had  been challenged with  newborn 
grafts  after  their  neonatal  treatment,  especially  on  those  hosts  which  had 
permanently accepted these grafts.  13 B6 mice (8 females and 5 males) irradi- 
ated with 500 R and inoculated with (A ×  B6) cells at birth, which had rejected 
neonatal A-strain skin grafts,  and  10 similarly treated mice  (3 females and 7 W.  K.  SILVERS,  S.  S.  WACHTEL,  AND  T.  W.  POOLE  1321 
TABLE  HI 
Survival of Neonatal Strain A  Skin Grafts on B6 Mice Inoculated at Birth with 20 
Million (A  × B6)FI Lymphoid Cells after Receiving 500 R 
No. of  ani- Sex of  recipients  Graft survival times  Surviving 
reals  >200 days 
13  ff 
22  mm 
35  ff and mm 
days  % 
15, 16, 20, 26, 54, 71, 85, 105, 106, 4 x  >200  31 
15, 39, >53,* 54, 80, 87, 93, >134,* 14 x  >200  64 
2 × 15, 16, 20, 26, 39, >53,* 2 x 54, 71, 80, 85, 87,  51 
93, 105, 106, >134,* 18 x  >200 
* Animal died with graft intact. 
TABLE IV 
Survival of Neonatal Strain A  Skin Grafts on B6 Mice Inoculated at Birth with 20 
Million (A  × B6)F1 Lymphoid Cells 
No. of an-  Sex of  recipients  imals  Graft survival times  MST  SD 
days 
ff  11  2 x 8, 9, 3 x  10, 2 x  11, 2 x  12, 19  9.5  1.16 
mm  12  2 × 8, 9, 10, 3 x 12, 15, 18, 20, 2 x 21  12.0  1.60 
ffand ram*  23  4 x 8, 2 x 9, 4 x 10, 2 x 11, 5 x 12, 15,  10.8  1.58 
18, 19, 20, 2 x 21 
* Eight females with grafts surviving 3 ×  10, 2 x  11, 2 x  12, and 19 days and nine males with 
grafts surviving 10, 3 x  12, 15, 18, 20, and 2 × 21 days tested for chimerism. 
males) which had accepted these grafts for 200 days were rechallenged with a 
second A  skin graft, this time from an adult donor.  The fate of these grafts is 
summarized in Table V. Whereas rejection of the initial neonatal A  strain skin 
graft was always followed by the destruction  (usually acute) of the subsequent 
adult graft, even in situations in which the neonatal graft had survived for more 
than 70 days, this was not the case when the neonatal graft had been accepted. 
Thus 8 of 10 animals bearing neonatal A  skin, retained both grafts in excellent 
condition  (Table V). 
Survival of Neonatal Strain A  Skin Grafts on B6 Mice which had Rejected 
Adult Strain A  Grafts.  Not only are neonatal  skin grafts frequently able to 
induce unresponsiveness of adult grafts on normal hosts but they are sometimes 
able  to  render  sensitized  animals  unresponsive  of  such  grafts  (10,  11).  To 
determine if this phenomenon might occur in the present situation,  15 animals 
which had rejected adult skin grafts after being exposed to 400 or 500 R and (A x 
B6) cells at birth were rechallenged with neonatal skin grafts 30-68 days after 
receiving the adult grafts. Although these neonatal grafts were almost always 
rejected and frequently in accelerated fashion (compare their survivals in Table 
VI with the survival of neonatal grafts shown in Table III), they persisted on 
four recipients.  One  animal  died  after the  neonatal  graft had  been on for 40 
days, but the other three recipients maintained the neonatal graft for 100 days 
at  which  time  they  received  a  second  adult  A-strain  skin  graft.  After  this 
procedure,  two  of the  hosts  promptly rejected  the  neonatal  graft  and  subse- 1322  BEHAVIOR  OF  sk-INCOMPATIBLE  SKIN  GRAFTS  ON  TOLERANT  MICE 
TABLE  V 
Survival of  Adult Strain A Skin Grafts on B6 Mice which had been Exposed 200 Days 
Previously to Neonatal Strain A Skin Grafts after Receiving 500 R and 20 Million (A × 
B6)F1 Lymphoid Cells at Birth 
No. of  ani-  Sex  Graft survival times adult graft/ 
reals  graft  survival times neonatal grai~ 
11  ff 
12  mm 
23  ff and mm 
days 
10/15, 9/16,  10/26,  15/54, 9/71,  9/85,  10/105,  10/106, 96/262, 
2 x  >100/>300 
18/15, 11/39, 15/54, 13/80, 12/93, 20/221, 6 x  >100/>300 
10/15, 18/15, 9/16, 10/26, 11/39, 2 x  15/54, 9/71,  13/80, 9/85, 
12/93, 10/105, 10/106, 20/221,  96/262, 8 x  >100/>300 
quently sloughed the adult graft as well. However, both grafts survived "perma- 
nently" on the third host (Table VI). 
Importance  of the Persistence of the Neonatal  Skin  Graft  in  Maintaining 
Unresponsiveness of the Adult Graft.  The persistence of tolerance apparently 
depends upon the persistence of antigen  (14). It follows that if neonatal skin 
grafts can induce tolerance to  Sk,  then the removal of these neonatal grafts 
before challenge with adult skin should terminate the unresponsive state (see 
reference 4). Indeed, unlike animals with persisting neonatal skin grafts, ani- 
mals which rejected these grafts, even after long periods of  time, always rejected 
subsequent adult A-strain grafts (in many instances acutely, see Table V). To 
ascertain the importance of the persistence of the neonatal grafts in rendering 
adult animals unresponsive of adult grafts, six neonatal grafts were removed 
after they had been in place on neonatally treated B6 males for 200 days. 50 days 
after this procedure the hosts were challenged with adult A-strain grafts. All of 
these adults grafts were rejected. Moreover, their survival times (20, 25, 35, 40, 
43, and 47 days) compared favorably with the survival of similar grafts on male 
recipients which had not been exposed to neonatal skin (see Table II). 
Survival of Adult B6 Skin Grafts on X-Irradiated A-Strain Mice Inoculated 
at Birth  with (A  × B6)  Cells.  The experiments reported above are all con- 
cerned with the behavior of A-strain skin grafts on B6 mice. However, it follows 
that if A-strain skin grafts possess Sk antigen absent in B6 mice, then B6 skin 
cells should possess an alternative allele at the relevant locus (assuming that 
the alternative is a  productive and not a  null allele) and express Sk antigen 
absent in A mice. 
To determine the capacity of A-strain animals to react against this putative 
B6  antigen,  the  survivors  of four litters  of strain  A  mice which had  been 
irradiated at birth with 500 R,  and inoculated with (A  ×  B6) lymphoid cells, 
were  challenged with  adult  B6  skin  grafts.  In  contrast  to  the  response  of 
similarly treated B6 animals to A-strain grafts, 8 of 10 survivors permanently 
accepted their B6 test grafts. Indeed, at no time during the 200 day observation 
period did the grafts display any signs  of rejection.  The two animals which 
rejected their B6 skin grafts did so in 29 and 71 days, respectively (Table VII). 
When these two rejectors were assayed for chimerism, B6 (H-2  b) antigens could 
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TABLE VI 
Survival of  Neonatal Strain A Skin Grafts on B6 Mice which had Rejected Adult Strain 
A Skin Grafts after being Irradiated and Inoculated at Birth with 20 Million (A × B6)FI 
Lymphoid Cells 
No. of an- 
X-ray dose  imals  Sex 
Interval be- 
tween adult 
and neonatal 
grafts 
Survival times adult graft/sur- 
vival times neonatal graft 
400 R 
500 R 
days  days 
2  ff  42  12/9, 13/9 
1  ff  30  13/11 
3  mm  30  13/>40,*  13/9, 13/12 
1  ff  40  16/12 
1  mm  40  25/15 
1  ff  42  23/>1005 
3  mm  42  20/15, 22/10, 24/>1005 
1  mm  56  41/11 
2  ram  68  27/78, 30/>100§ 
* Animal died with graft intact. 
5 These animals were regrafted with a second adult strain A skin graft after the neonatal graft 
had survived for 100 days. The female rejected its neonatal graft 9 days after challenge with the 
adult graft and the second adult graft survived for 43 days. The male accepted the second adult A 
graft for more than  100  days and  its neonatal graft  also remained in excellent condition, 
surviving for >200 days. 
§ This animal was regrafted with a second adult strain A skin graft ai~r the neonatal graft had 
survived for 100 days but was undergoing rejection. The neonatal graft was destroyed at 112 days 
and the second adult A graft survived for 30 days. 
TABLE  VII 
Survival of  Adult B6 Skin Grafts on Strain A  Mice Inoculated at 
Birth with 20 Million (A  x  B6)F1 Lymphoid Cells after 
Receiving 500 R 
No. of animals  Sex  Graft survival times 
days 
3  ff  29, 71, >200 
7  mm  7 x  >200 
10  ffand mm  29,* 71,* 8 x  >200 
* Tested for chimerism. 
Discussion 
Our results with neonatally treated mice are in accord with those of Boyse and 
his associates (4) with lethally irradiated and restored adult mice. Thus B6 mice 
X  irradiated  at  birth  and  inoculated  immediately  thereafter  with  (A  ×  B6) 
lymphoid cells are apparently  rendered  tolerant of the foreign antigens  present 
on these cells, but not on A-strain skin, since the hosts reject A  skin grafts even 
though they are persistent leukocyte chimeras.  We conclude, therefore, that the 
prompt rejection of the A-skin grafts occurs not only because the hosts are naive 
with respect to A-strain Sk antigens,  but also because the cells of the  (A ×  B6) 
inoculum  lose  tolerance  of these  antigens  as  a  result  of their  transfer  to  an 1324  BEHAVIOR  OF  sk-INCOMPATIBLE  SKIN  GRAFTS  ON  TOLERANT  MICE 
environment in which the antigens are not expressed. Consequently the A skin 
grafl~ are most probably rejected by the combined action of radiation resistant 
host cells and of the descendants of the F1 hybrid cells inoculated neonatally. 
Other evidence indicating the existence of Sk-differentiation alloantigens is 
provided by the observation that the serum of (B6  × A) --* B6 chimeras which 
have rejected strain A skin grafts, is cytotoxic for dispersed strain A epidermal 
cells but not strain A  lymphoid cells  (15). Moreover, leukocytes from these 
tolerant mice are stimulated in mixed cultures by strain A epidermal cells but 
not by strain A leukocytes (16). The antigens have been designated Sk.1 and 
Sk.2 in strains A  and B6,  respectively (4). More recently evidence has been 
obtained that in B6 and A mice two independently segregating loci determine 
expression of Sk antigens (Wachtel and Boyse, unpublished data). Preliminary 
data indicate that incompatibility with regard to the Sk antigens determined  by 
both these loci in A-strain mice results in more rapid rejection of A skin grafts 
by (B6  x  A) --* (B6  ×  A)  x  B6 backcross chimeras than incompatibility with 
regard to either of these antigens alone. 
Since, in contrast to the destruction of all adult strain A skin grafts by B6 
animals rendered chimeric at birth,  only 2  of 10  adult B6  skin grafl~ were 
rejected by similarly treated A newborn mice, we assume that the Sk.2 antigens 
are not as strong in A animals as Sk. 1 antigens are in B6 mice. In fact, the two 
strain A animals which eventually rejected their B6 skin grafts evidently did so 
not because they were able to react specifically against the Sk antigens present 
in  their  B6  skin  grafts,  but  rather  because of a  loss  of chimerism which 
permitted them  to  regain  competence with  respect to  all  foreign antigens 
present in the graft (14). This weaker response on the part of neonatally treated 
A-strain animals against B6 skin has also been reported in lethally irradiated 
adult A-strain mice restored with (B6  ×  A) marrow and spleen cells. In this 
situation, however, the immunologic response of approximately 50% of the A 
animals which eventually rejected their B6 skin grafts appears to have been 
directed solely against Sk antigens of the graft (3). 
The uniformity  with which B6 mice irradiated at birth and inoculated with (A 
×  B6)  lymphoid cells  reject adult  A-strain  skin  grafts,  contrasts  with  the 
frequent acceptance of neonatal A skin grafts by similarly treated hosts. More- 
over, the persistence of these grafts often results in acceptance of subsequent 
adult A skin grafts. This ability of neonatal A-strain skin to induce unrespon- 
siveness of adult A-strain skin in chimeric B6 mice, provides further evidence 
that the rejection of the adult grafts by similar hosts not previously exposed to 
newborn skin, is due to their capacity to respond to Sk antigens. It also indicates 
that Sk antigens behave like other weak transplantation antigens since these 
too may induce unresponsiveness when presented in newborn skin (10, 11). This 
similarity includes the infrequent capacity of neonatal skin grafts to transform 
sensitized hosts into unresponsive animals (10, 11). 
The fact that neonatal skin grafts may induce unresponsiveness of Sk anti- 
gens is advantageous in studies concerned with the relationship between per- 
sistence of antigen and the form in which it persists, and the maintenance of  the 
unresponsive state. In this case, the tolerance maintaining antigens are con- 
fined to the graft itself and so removal of the graft allows one to eliminate the W.  K.  SILVERS,  S,  S.  WACHTEL,  AND  T.  W.  POOLE  1325 
source of persisting antigen. Thus, whereas animals exposed to neonatal grafts 
for  200  days  are  usually  unresponsive  to  adult  skin  gra~s,  removal  of the 
neonatal grafts for 50 days before challenge with adult skin is sufficient to break 
tolerance.  These  results  are  similar  to  those  obtained  in  studies  with  H-Y 
antigen  (10) and provide a  useful basis for determining the factors responsible 
for the maintenance of unresponsiveness to Sk antigens. 
Steinmuller and Lofgreen (17) also present evidence that A and B6 mice differ 
with respect to at least one Sk antigen and that this can function as a histocom- 
patibility antigen.  They report that  (B6  x  A) -~ B6 radiation chimeras accept 
neonatal A-strain heart tissue but not neonatal A-strain skin. This difference in 
the survival of neonatal skin grafts (compared with our findings) is probably due 
to  the  fact that  they used  skin  grafts  only 2  mm  in  diameter.  Finally,  our 
observation  that  adult  and  neonatal  A-strain  skin  grafts  persist  longer  on 
treated  males  than  on treated  females,  agrees  with  several  other reports  in 
which,  under  a  variety of conditions,  females display greater  immunological 
reactivity than males (11). 
Summary 
It has been reported that lethally irradiated adult B6 mice restored with (A × 
B6) hemopoietic cells subsequently reject adult A-strain skin grafts because they 
are not tolerant  of A-strain  skin-specific  (Sk) antigens.  This  thesis  has been 
confirmed by a  series of experiments conducted on neonatally treated animals. 
Thus sublethally irradiated neonatal B6 mice, inoculated with (A × B6) lymph- 
oid  cells,  permanently  accept these  cells  while  subsequently  rejecting  adult 
strain A skin grafts. Further evidence that the destruction of  these grafts results 
from  the  reaction  of the  host  to  Sk  antigens,  is  provided  by the  fact  that 
similarly  treated  recipients often permanently  accept neonatal  A-strain  skin. 
Such grafts usually induce tolerance of adult A-strain skin grafts. 
Received for publication 17 February 1976. 
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